Trump Brings Drug Manufacturing Back to America
The Trump administration approved a partnership with Kodak to produce critical pharmaceutical ingredients in the United States. “America is dangerously dependent on foreign supply chains for all three stages of drug production: starting materials used to manufacture active ingredients, the active ingredients themselves and the finished product in the form of tablets,